What's New

  • 18 Jan 2022
    Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue Read More

  • 12 Jan 2022
    Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources Read More

  • 11 Jan 2022
    Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue Read More

$3.2700
$-0.0800
-2.3881%
Quotes delayed at least 15 minutes